Oral Topotecan Combined With Anlotinib in Patients With Platinum-resistant Recurrent Ovarian Cancer
Clinical trial NCT05736952 · WITHDRAWN
Trial details
- NCT number
- NCT05736952
- Sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2026-02-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.